ArticleFrontiers in pharmacology2025

Severe cutaneous adverse reactions to anti-osteoporosis drugs: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System database and a review of published cases.

Jun-Wei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.